Opentrons has launched Compliance Ready Software (CRS) for its Flex liquid-handling robot, giving the company's roughly 10,000 worldwide installations a path to comply with strict US Food and Drug Administration rules covering electronic records. The announcement, made May 19, 2026 ahead of a debut at SLAS Europe 2026 in Hamburg, frames CRS as the first FDA 21 CFR Part 11-aligned software designed for an accessible benchtop liquid handler.
What Compliance Ready Software adds
CRS layers a regulated software stack onto the existing Flex platform. The package brings authentication, signed audit trails, role-based access, and electronic record integrity to the robot, turning a low-cost benchtop system into an audit-ready automation option. Opentrons says the total cost of ownership is roughly five times lower than purpose-built GxP liquid handling systems.
The software is aimed at non-GMP regulated environments, including pharma and biotech R&D, discovery and preclinical operations, contract research and contract development manufacturing organizations running non-GMP services, GLP and GCP laboratories, and medical-device manufacturers' R&D and design verification teams. General availability is scheduled for August 2026.
Why the move matters
The Flex robot was introduced in 2023 as a modular, open-source liquid handler with swappable pipettes from 1 to 96 channels, an on-deck thermocycler and heater-shaker, and a magnetic plate. Opentrons has historically targeted academic and startup labs priced out of legacy systems. Adding Part 11 compliance opens doors to regulated workflows in pharma and biotech where audit trails and electronic signatures are mandatory.
The launch follows a series of recent product moves from Opentrons. Earlier this year the company introduced dynamic protocol simulation tooling for AI-generated workflows and named James Atwood, its global robotics chief, as chief executive. CRS also extends the Flex into segments adjacent to FDA-cleared clinical software for medical imaging, where regulated electronic records are routine.
Lower cost, broader reach
By keeping CRS aligned with the Flex's open architecture and its hundreds of community protocols, Opentrons is betting that smaller and mid-sized labs will move regulated work off paper or off legacy automation. The company says CRS will let regulated teams use a single platform for both early discovery work and validated runs, simplifying compliance overhead.
The launch event in Hamburg includes one-on-one demonstrations of CRS on the Flex by appointment at SLAS Europe Booth 208. Opentrons has positioned CRS as part of a broader push to make professional-grade lab automation accessible across the life sciences market.
Context: lab robots become regulated infrastructure
The move arrives as automated laboratories scale across pharma, biotech, and clinical research. Adjacent efforts include Cornerstone Robotics' EU CE mark for the Sentire surgical robot and a rising tide of medical-device clearances, signaling that regulators are catching up with the increasingly software-defined nature of laboratory hardware. With CRS, Opentrons is making the case that lower-cost benchtop systems can be just as audit-ready as the seven-figure liquid handlers they aim to displace.
Reporting based on coverage from Business Wire and The Robot Report.